Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2008 Jul 30:7:144.
doi: 10.1186/1475-2875-7-144.

Evaluation of the genetic polymorphism of Plasmodium falciparum P126 protein (SERA or SERP) and its influence on naturally acquired specific antibody responses in malaria-infected individuals living in the Brazilian Amazon

Affiliations

Evaluation of the genetic polymorphism of Plasmodium falciparum P126 protein (SERA or SERP) and its influence on naturally acquired specific antibody responses in malaria-infected individuals living in the Brazilian Amazon

Lilian Rose Pratt-Riccio et al. Malar J. .

Abstract

Background: The Plasmodium falciparum P126 protein is an asexual blood-stage malaria vaccine candidate antigen. Antibodies against P126 are able to inhibit parasite growth in vitro, and a major parasite-inhibitory epitope has been recently mapped to its 47 kDa N-terminal extremity (octamer repeat domain--OR domain). The OR domain basically consists of six octamer units, but variation in the sequence and number of repeat units may appear in different alleles. The aim of the present study was to investigate the polymorphism of P126 N-terminal region OR domain in P. falciparum isolates from two Brazilian malaria endemic areas and its impact on anti-OR naturally acquired antibodies.

Methods: The study was carried out in two villages, Candeias do Jamari (Rondonia state) and Peixoto de Azevedo (Mato Grosso state), both located in the south-western part of the Amazon region. The repetitive region of the gene encoding the P126 antigen was PCR amplified and sequenced with the di-deoxy chain termination procedure. The antibody response was evaluated by ELISA with the Nt47 synthetic peptide corresponding to the P126 OR-II domain.

Results: Only two types of OR fragments were identified in the studied areas, one of 175 bp (OR-I) and other of 199 bp (OR-II). A predominance of the OR-II fragment was observed in Candeias do Jamari whereas in Peixoto de Azevedo both fragments OR-I and OR-II were frequent as well as mixed infection (both fragments simultaneously) reported here for the first time. Comparing the DNA sequencing of OR-I and OR-II fragments, there was a high conservation among predicted amino acid sequences of the P126 N-terminal extremity. Data of immune response demonstrated that the OR domain is highly immunogenic in natural conditions of exposure and that the polymorphism of the OR domain does not apparently influence the specific immune response.

Conclusion: These findings confirm a limited genetic polymorphism of the P126 OR domain in P. falciparum isolates and that this limited genetic polymorphism does not seem to influence the development of a specific humoral immune response to P126 and its immunogenicity in the studied population.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Alignment of the predicted amino acid sequences of P126 OR region from Candeias do Jamari and Peixoto de Azevedo P. falciparum isolates (GenBank accession number EU360815 and EU360816). The OR fragments OR-I and OR-II from Brazil were compared one each other and to FCR3 and Honduras1 OR described sequences reported by Morimatsu and others [22] and Liu and others [35]. The motif insertion is underlined, the lake of corresponding residues is indicated by dash, different residues are indicated in boldface letters and two (OR-I) or three (OR-II) antigenic determinants are in box.
Figure 2
Figure 2
Comparison of the predictive regions of the OR domain. The two (OR-I) or three (OR-II) antigenic determinants are in box.

Similar articles

Cited by

References

    1. Perrin LH, Loche M, Dedet JP, Roussilhon C, Fandeur T. Immunization against Plasmodium falciparum assexual blood stages using soluble antigens. Clin Exp Immunol. 1984;56:67–72. - PMC - PubMed
    1. Banyal HS, Inselburg J. Isolation and characterization of parasite-inhibitory Plasmodium falciparum monoclonal antibodies. Am J Trop Med Hyg. 1985;34:1055–1064. - PubMed
    1. Delplace P, Dobbremetz JF, Fortier B, Vernes A. A 50 kilodalton exoantigen specific to the merozoite relase-reinvasion stage of Plasmodium falciparum. Mol Biochem Parasitol. 1985;17:239–251. doi: 10.1016/0166-6851(85)90021-0. - DOI - PubMed
    1. McCoubrie JE, Miller SK, Sargeant T, Good RT, Hodder AN, Speed TP, de Koning-Ward TF, Crabb BS. Evidence for a common role for the serine-type Plasmodium falciparum serine repeat antigen proteases: implications for vaccine and drug design. Infect Immun. 2007;75:5565–5574. doi: 10.1128/IAI.00405-07. - DOI - PMC - PubMed
    1. Debrabant A, Delplace P. Leupeptin alters the proteolytic processing of p126, the major parasitophorous vacuole antigen of Plasmodium falciparum. Mol Biochem Parasitol. 1989;33:151–158. doi: 10.1016/0166-6851(89)90029-7. - DOI - PubMed

Publication types

Substances

LinkOut - more resources